FIELD: organic chemistry, heterocyclic compounds, medicine, pharmacy. SUBSTANCE: invention relates to novel derivatives of purine of formulas (I) , (II) , (III) and (IV) , pharmaceutical composition based on thereof and method of treatment of morbid state characterized by thrombosis activity. In compounds (I), (II), (III) and (IV) Z1 and Z2 each means -O-; R1 means hydrogen atom or OR10; R2 means +C(NH)-NH2; R3 means +C(O)N-(R10)R11, (1,2)-tetrahydropyrimidinyl (optionally substituted with alkyl), (1,2)-imidazolyl (optionally substituted with alkyl) or (1,2)-imidazolinyl (optionally substituted with alkyl); R4 means hydrogen atom; R5 means alkyl or aralkyl; R6 means alkyl, aralkyl or (C(R7)(R8)n-R9; R7 means alkyl, ; or R7 means aralkyl (optionally substituted with one or more substitutes taken among group comprising of halogen atom, hydroxy-group and OP(O)-(OR10)2); or R7 means imidazolylalkyl or indolylalkyl; R8 means hydrogen atom or alkyl; R9 means -C(O)O-R10 or +C(O)N-(R10)R11; each of R10 and R11 means independently hydrogen atom or alkyl; R12 means linear or branched alkylene chain; and R13 means alkyl or aryl. Invention relates also to pharmaceutical composition showing inhibitory activity with respect to factor Xa that involves therapeutically effective amount of compounds of formulas (I), (II), (III), and (IV) and to method of treatment of human morbid state involving administration of therapeutically effective dose of indicated compounds. EFFECT: improved method of treatment, valuable medicinal properties of compounds and composition. 8 cl
Title | Year | Author | Number |
---|---|---|---|
BICYCLIC DERIVATIVES OF PYRIMIDINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2198884C2 |
INHIBITOR OF EGFR AND PRODUCTION AND USE THEREOF | 2015 |
|
RU2702631C2 |
5-SUBSTITUTED DERIVATIVES OF 1,1-DIOXO-1,2,5-THIAZOLIDIN-3-ONE AS PTPase 1B INHIBITORS | 2003 |
|
RU2349589C2 |
COMBINATIONS OF ACTIVATOR (ACTIVATORS) OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR), AND INHIBITOR (INHIBITORS) OF STEROL ABSORPTION AND TREATMENT OF VASCULAR DISEASES | 2008 |
|
RU2483724C2 |
PHOSPHOINOSITIDE-3-KINASE INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID INHIBITORS | 2007 |
|
RU2437888C2 |
NEW BISPIDINE COMPOUNDS USEFUL IN TREATMENT OF CARDIAC ARRHYTHMIAS | 2000 |
|
RU2250903C2 |
SUBSTITUTED PYRAZOLE DERIVATIVES, THEIR INTERMEDIATES, HERBICIDE COMPOSITION, AND WEED CONTROL METHOD | 1993 |
|
RU2137771C1 |
TYPE 1 DIACYLGLYCEROL-O-ACYLTRANSFERASE ENZYME INHIBITORS | 2008 |
|
RU2486186C2 |
DERIVATIVES OF THIENO[2,3-D]PYRIMIDINE-2,4-(1H,3H)-DIANE, PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PREPARING, METHOD FOR IMMUNOSUPPRESSION AND METHOD FOR TREATMENT OR REDUCING RISK OF RESPIRATORY WAY OBSTRUCTION | 1998 |
|
RU2225410C2 |
SUBSTITUTED DERIVATIVES OF PYRAZOLE AND AGENT EXHIBITING HERBICIDE ACTIVITY | 1995 |
|
RU2154644C2 |
Authors
Dates
2002-10-27—Published
1997-08-14—Filed